Shorla Oncology are proud supporters of the 30 % club in Ireland, who’s collaborative concerted business-led efforts help accelerate towards diversity at all levels of organisations.
Orlaith Ryan CTO, presented at a recent council event on the subject of diversity in clinical trials during research and development. This presentation gave a technical perspective and shared some previous insight and experience on the topic, reiterating the importance of diversity in science and the benefits of same for all stakeholders.
Shorla look forward to participating in future information sharing and advocacy events.
